Huikai Li
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 23
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 6
- Cancer, Lipids, and Metabolism 5
-
- Pancreatic and Hepatic Oncology Research 10
- Colorectal Cancer Treatments and Studies 4
- Pathology and Forensic Medicine top 10%
- Cancer Mechanisms and Therapy 8
-
- Ferroptosis and cancer prognosis 4
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 9
- Co-authors
- Ti ZhangQiang LiYunlong CuiWei ZhangTianqiang SongZhisheng LiuWeidong MaQiang Wu
- Cited by
- HepatologyCancer ResearchOncology
- Journals
- Journal of Clinical Oncology (4 papers)Journal of Controlled Release (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Huikai Li
43 papers receiving 744 citations
Peers
Comparison fields: 5 of 73
- Hepatology 287
- Cancer Research 182
- Oncology 218
- Pathology and Forensic Medicine 117
- Pulmonary and Respiratory Medicine 152
Countries citing papers authored by Huikai Li
This map shows the geographic impact of Huikai Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huikai Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huikai Li more than expected).
Fields of papers citing papers by Huikai Li
This network shows the impact of papers produced by Huikai Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huikai Li. The network helps show where Huikai Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huikai Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 12 | |
| 5 | 2023 | 16 | |
| 6 | 2022 | 4 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 6 | |
| 9 | 2021 | 2 | |
| 10 | 2020 | 9 | |
| 11 | 2020 | 26 | |
| 12 | 2017 | 41 | |
| 13 | 2017 | 10 | |
| 14 | 2016 | 57 | |
| 15 | 2016 | 3 | |
| 16 | 2014 | 28 | |
| 17 | 2013 | 23 | |
| 18 | 2010 | 6 | |
| 19 | 2008 | 5 | |
| 20 | 2007 | 46 |
About Huikai Li
Huikai Li is a scholar working on Hepatology, Cancer Research and Oncology, having authored 47 papers that have together received 753 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (23 papers), Pancreatic and Hepatic Oncology Research (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Cancer Mechanisms and Therapy (8 papers), Cancer, Hypoxia, and Metabolism (6 papers), Cancer, Lipids, and Metabolism (5 papers), Ferroptosis and cancer prognosis (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). The work is most often cited by research in Hepatology (287 citations), Cancer Research (182 citations) and Oncology (218 citations). Huikai Li has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Ti Zhang, Qiang Li, Yunlong Cui, Wei Zhang, Tianqiang Song, Zhisheng Liu, Weidong Ma, Qiang Wu, Hongyuan Zhou and Feng Wang. Their work appears in journals such as Journal of Clinical Oncology, Journal of Controlled Release and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.